Lasofoxifene Tartrate CAS 190791-29-8 Daahirnimada Chiral ≥99.0% Daahirnimada

Sharaxaad Gaaban:

Magaca Kiimikada: Lasofoxifene Tartrate

CAS: 190791-29-8

Muuqashada: Caddaan ilaa budo cad-cad

Nadiifnimada Chiral: ≥99.0%Daahirsanaanta: ≥98.0% (HPLC)

Marka lagu daweynayo lafo-jileeceedka ka dib

API Tayada Sare, Wax soo saarka Ganacsiga

Inquiry: alvin@ruifuchem.com

Email noogu soo dir

Faahfaahinta Alaabta

Alaabooyinka La Xiriira

Tags Product

Sharaxaad:

Soo saaraha soo saaraha oo leh nadiif sare iyo tayo xasilan
Magaca Kiimikada: Lasofoxifene Tartrate
CAS: 190791-29-8
Lasofoxifene Tartrate (CAS: 190791-29-8) ee daawaynta lafo-beelka postmenopausal

Guryaha Kiimikada:

Magaca Kiimikada	Lasofoxifene Tartrate
La mid ah	(5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol Tartrate Oporia
Lambarka CAS	190791-29-8
Lambarka CAT	RF-API20
Heerka Saamiyada	Kaydka, Miisaanka Wax-soo-saarka Ilaa boqollaal Kiilogaram
Qaanuunka molecular	C28H31NO2.ClH
Miisaanka Molecular	450.019
Summada	Kiimikada Ruifu

Tilmaamaha:

Shayga	Tilmaamaha
Muuqashada	Caddaan ilaa budo cad-cad
Qoyaanka (KF)	≤0.50%
Biraha culus	≤20pm
Daahirnimada Chiral	≥99.0%
Daahirnimada / Habka Falanqaynta	≥98.0% (HPLC)
Khasaare xagga qalajinta	≤0.50%
Hadhaaga dabka	≤0.50%
Heerka Imtixaanka	Farmashiyaha Shiinaha (CP);Heerka Ganacsiga
Isticmaalka	Walaxda Farmashiyeed ee Firfircoon (API);Lafo-jileecu ka dib

Xidhmada & Kaydinta:

Xidhmada: Dhalo, boorsada aluminium aluminium, durbaanka kartoonada, 25kg/Drum, ama sida waafaqsan shuruudaha macmiilka.

Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka, qoyaanka iyo cayayaanka.

Faa'iidooyinka:

FAQ:

Codsiga:

Shanghai Ruifu Chemical Co., Ltd. waa hormuudka soo saaraha iyo alaab-qeybiyaha Lasofoxifene Tartrate (CAS: 190791-29-8) oo leh tayo sare.
Lasofoxifene Tartrate waa jiilka saddexaad, modulator-ka soo-dhoweynta estrogen-ka ee aan isteeroyda ahayn (SERM).Waxay si xushmad leh ugu xidhaa ERalpha bini'aadamka oo leh qiime IC50 ah 1.5 nM waxayna ka hortagtaa luminta lafaha jiirka ugxan-sidaha.Daraasadaha kiliinikada ee osteoporosis postmenopausal, 0.5 mg / maalin lasofoxifene ayaa lala xiriiriyay khataraha yaraaday ee jabka aan vertebral iyo vertebral, kansarka naasaha ER-positive, cudurada wadnaha wadnaha, iyo istaroogga laakiin khatarta sii kordheysa ee dhacdooyinka thromboembolic venous.Lasofoxifene ayaa sidoo kale lagu muujiyay inuu u dhaqmo sidii agonist-ka soo horjeeda ee CB2 cannabinoid reseptor, taasoo muujinaysa awooddeeda in dib loo soo celiyo sida daaweynta calaamadaha CB2 waa bartilmaameed.